NDT Advance Access published online on December 7, 2005
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfi312
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Medical Genetics, Department of Molecular Biology, University of Siena, Italy
* To whom correspondence should be addressed. Background. Alport syndrome (ATS) is a progressive inherited nephropathy characterized by irregular thinning, thickening and splitting of the glomerular basement membrane (GBM) often associated with hearing loss and ocular symptoms. ATS has been shown to be caused by COL4A5 mutations in its X-linked form and by COL4A3 and COL4A4 mutations in its autosomal forms. Methods. Five families with a suspicion of ATS were investigated both from a clinical and molecular point of view. COL4A3 and COL4A4 genes were analysed by DHPLC. Automated sequencing was performed to identify the underlying mutation. Results. Molecular analysis indicated that in all 5 cases the correct diagnosis was autosomal recessive ATS. In three families in which parental consanguinity clearly pinpointed to autosomal recessive ATS, we found COL4A4 homozygous mutations in two of them and COL4A3 homozygous mutation in the other one. In the remaining two families a differential diagnosis including X-linked ATS, autosomal recessive ATS and thin basement membrane nephropathy was considered. The molecular analysis demonstrated that the probands were genetic compounds for two different mutations in the COL4A4 gene pinpointing to the correct diagnosis of autosomal recessive ATS. Conclusions. A clinical evaluation of probands and their relatives of the five families carrying mutations in either the COL4A3 or the COL4A4 gene was carried out to underline the natural history of the autosomal recessive ATS. In addition, this paper stresses the complexity of the clinics and genetics of ATS and how a correct diagnosis is based on a combination of: (i) an in-depth clinical investigation; (ii) a detailed formal genetic analysis; (iii) a correct technical choice of the gene to be investigated; (iv) a correct technical choice of the family member to be included in the mutational screening. A correct diagnosis is the basis for an appropriate genetic counselling dealing with both the correct prognosis and the accurate recurrence risk for the patients and family members.
Received August 10, 2005
Accepted November 11, 2005
Original Article
Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families
Ilaria Longo 1,
Elisa Scala 1,
Francesca Mari 1,
Rossella Caselli 1,
Chiara Pescucci 1,
Maria Antonietta Mencarelli 1,
Caterina Speciale 1,
Marisa Giani 2,
Elena Bresin 3,
Domenica Angela Caringella 4,
Zvi-Uri Borochowitz 5,
Komudi Siriwardena 6,
Ingrid Winship 6,
Alessandra Renieri 1 *,
and
Ilaria Meloni 1
2 Clinica Pediatrica "G. e D. De Marchi", University of Milano, Italy
3 Centro Ricerche Cliniche Malattie Rare, Villa Camozzi Ranica, Bergamo, Italy
4 Dipartimento di Medicina Pediatrica, Ospedale Regionale Pediatrico Giovanni XXIII, Bari, Italy
5 Simon Winter Institute for Human Genetics, Bnai-Zion Medical Center, Technion-Rappaport Faculty of Medicine, Haifa, Israel
6 Northern Regional Genetic Service, Auckland Hospital, New Zealand
Alessandra Renieri, E-mail: renieri{at}unisi.it
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Pierides, K. Voskarides, Y. Athanasiou, K. Ioannou, L. Damianou, M. Arsali, M. Zavros, M. Pierides, V. Vargemezis, C. Patsias, et al. Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2721 - 2729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Marcocci, V. Uliana, M. Bruttini, R. Artuso, M. C. Silengo, M. Zerial, F. Bergesio, A. Amoroso, S. Savoldi, M. Pennesi, et al. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1464 - 1471. [Abstract] [Full Text] [PDF]
|
|